DrugPatentWatch Database Preview
Details for Patent: 8,734,847
Which drugs does patent 8,734,847 protect, and when does it expire?
Patent 8,734,847 protects TIVORBEX and is included in one NDA.
This patent has thirty-four patent family members in twenty countries.
This patent has thirty-four patent family members in twenty countries.
Summary for Patent: 8,734,847
| Title: | Formulation of indomethacin |
| Abstract: | The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments. |
| Inventor(s): | Dodd; Aaron (Nedlands, AU), Meiser; Felix (Claremont, AU), Norret; Marck (Darlington, AU), Russell; Adrian (Rivervale, AU), Bosch; H William (Bryn Mawr, PA) |
| Assignee: | Iceutica Py Ltd. (Philadelphia, PA) |
| Application Number: | 13/776,536 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,734,847
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iroko Pharms Llc | TIVORBEX | indomethacin | CAPSULE;ORAL | 204768-001 | Feb 24, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Iroko Pharms Llc | TIVORBEX | indomethacin | CAPSULE;ORAL | 204768-002 | Feb 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 8,734,847
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Australia | 2009901745 | Apr 24, 2009 |
Non-Orange Book US Patents Family Members for Patent 8,734,847
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,095,496 | Formulation of indomethacin | ➤ Sign Up |
| 9,522,135 | Formulation of indomethacin | ➤ Sign Up |
| 8,992,982 | Formulation of indomethacin | ➤ Sign Up |
| 9,849,111 | Formulation of indomethacin | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 8,734,847
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3628 | ➤ Sign Up | |||
| Australia | 2010239081 | ➤ Sign Up | |||
| Australia | 2014202776 | ➤ Sign Up | |||
| Australia | 2016200397 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
